                         SEQUENCE LISTING

<110>  Dana-Farber Cancer Institute, Inc.
 
<120>  HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES

<130>  D0504.70116WO00

<140>  Not Yet Assigned
<141>  2017-04-28

<150>  US 62/329,406
<151>  2016-04-29

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  1
gctgtgattt ggaagggaa                                                    19


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  2
ggatagcgag accactaaa                                                    19


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  3
ggagcaatat actatcata                                                    19


<210>  4
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  4
ggaactgtct agtatctta                                                    19


<210>  5
<211>  24
<212>  PRT
<213>  Homo sapiens

<400>  5

Val Ala Val Lys Thr Leu Lys Pro Gly Thr Met Ser Val Gln Ala Phe 
1               5                   10                  15      


Leu Glu Glu Ala Asn Leu Met Lys 
            20                  


<210>  6
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  6

Gln Gly Ala Lys Phe Pro Ile Lys Trp Thr Ala Pro Glu Ala Ala Leu 
1               5                   10                  15      


Tyr Gly Arg 
            


